Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Array Technologies, Inc. stock logo
ARRY
Array Technologies
$8.20
+0.9%
$7.49
$5.03
$12.23
$1.25B1.765.99 million shs8.51 million shs
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$24.07
-8.1%
$23.85
$11.83
$27.72
$11.96B1.695.07 million shs11.81 million shs
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
$14.55
$14.80
$9.20
$18.67
$6.84B0.331 shsN/A
The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Array Technologies, Inc. stock logo
ARRY
Array Technologies
-0.13%+9.21%+17.20%-26.60%+58.62%
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
+13.70%+20.14%+14.91%+7.93%+174.99%
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
0.00%0.00%0.00%-4.40%+14.13%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Array Technologies, Inc. stock logo
ARRY
Array Technologies
$8.20
+0.9%
$7.49
$5.03
$12.23
$1.25B1.765.99 million shs8.51 million shs
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$24.07
-8.1%
$23.85
$11.83
$27.72
$11.96B1.695.07 million shs11.81 million shs
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
$14.55
$14.80
$9.20
$18.67
$6.84B0.331 shsN/A
The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Array Technologies, Inc. stock logo
ARRY
Array Technologies
-0.13%+9.21%+17.20%-26.60%+58.62%
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
+13.70%+20.14%+14.91%+7.93%+174.99%
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
0.00%0.00%0.00%-4.40%+14.13%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Array Technologies, Inc. stock logo
ARRY
Array Technologies
2.36
Hold$10.3526.22% Upside
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
2.77
Moderate Buy$28.2017.18% Upside
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest ARRY, ELAN, and OPHLF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2026
Array Technologies, Inc. stock logo
ARRY
Array Technologies
Reiterated RatingBuy$10.00 ➝ $11.00
5/7/2026
Array Technologies, Inc. stock logo
ARRY
Array Technologies
Boost Price TargetOverweight$9.00 ➝ $10.00
5/7/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Boost Price TargetBuy$30.00 ➝ $31.00
5/7/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Boost Price TargetOverweight$28.00 ➝ $30.00
4/27/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
UpgradeSell (D)Sell (D+)
4/24/2026
Array Technologies, Inc. stock logo
ARRY
Array Technologies
UpgradeSell (E+)Sell (D-)
4/21/2026
Array Technologies, Inc. stock logo
ARRY
Array Technologies
Boost Price TargetBuy$11.00 ➝ $12.00
4/17/2026
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
UpgradeHold
4/16/2026
Array Technologies, Inc. stock logo
ARRY
Array Technologies
Lower Price TargetOverweight$11.00 ➝ $9.00
4/15/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Initiated CoverageBuy$30.00
4/14/2026
Array Technologies, Inc. stock logo
ARRY
Array Technologies
Set Price TargetBuy$11.00
(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Array Technologies, Inc. stock logo
ARRY
Array Technologies
$1.28B0.98$2.00 per share4.09($1.35) per share-6.07
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$4.72B2.54$2.43 per share9.91$13.18 per share1.83
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
$3.20B2.14$1.08 per share13.50$11.07 per share1.31
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Array Technologies, Inc. stock logo
ARRY
Array Technologies
-$52.24M-$0.73N/A10.791.19-4.07%-141.67%9.91%N/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-$232M-$0.48N/A20.572.93-4.92%7.16%3.53%N/A
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
$330.31M$0.8916.3515.65N/A12.29%7.76%5.91%5/8/2026 (Estimated)

Latest ARRY, ELAN, and OPHLF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2026N/A
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
$0.0520N/AN/AN/A$706.77 millionN/A
5/6/2026Q1 2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$0.34$0.40+$0.06$0.11$1.28 billion$1.37 billion
2/25/2026Q4 2025
Array Technologies, Inc. stock logo
ARRY
Array Technologies
$0.0020-$0.01-$0.0120-$1.06$211.13 million$226.04 million
2/24/2026Q4 2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$0.11$0.13+$0.02-$0.56$1.09 billion$1.14 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Array Technologies, Inc. stock logo
ARRY
Array Technologies
N/AN/AN/AN/AN/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
N/AN/AN/AN/AN/A
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Array Technologies, Inc. stock logo
ARRY
Array Technologies
N/A
2.31
1.91
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
0.60
2.17
1.08
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
0.10
3.02
2.56

Institutional Ownership

CompanyInstitutional Ownership
Array Technologies, Inc. stock logo
ARRY
Array Technologies
N/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
97.48%
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
N/A

Insider Ownership

CompanyInsider Ownership
Array Technologies, Inc. stock logo
ARRY
Array Technologies
0.64%
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
1.14%
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Array Technologies, Inc. stock logo
ARRY
Array Technologies
1,200153.04 million152.07 millionOptionable
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
9,400497.17 million491.50 millionOptionable
Ono Pharmaceutical Co. stock logo
OPHLF
Ono Pharmaceutical
4,287469.91 millionN/ANot Optionable

Recent News About These Companies

ONO-4685 by Ono Pharmaceutical for T-Cell Lymphomas: Likelihood of Approval

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Array Technologies stock logo

Array Technologies NASDAQ:ARRY

$8.20 +0.07 (+0.86%)
Closing price 04:00 PM Eastern
Extended Trading
$8.25 +0.05 (+0.65%)
As of 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Array Technologies, Inc. manufactures and sells ground-mounting tracking systems used in solar energy projects in the United States, Spain, Brazil, Australia, and internationally. The company operates in two segments, Array Legacy Operations and STI Operations. Its products portfolio includes DuraTrack HZ v3, a single axis tracker; Array STI H250 that delivers a lower levelized cost of energy with tracker system; Array OmniTrack; and SmarTrack, a software product that uses site-specific historical weather and energy production data in combination with machine learning algorithms to identify the optimal position for a solar array in real time to enhance energy production. Array Technologies, Inc. was incorporated in 1987 and is headquartered in Albuquerque, New Mexico.

Elanco Animal Health stock logo

Elanco Animal Health NYSE:ELAN

$24.06 -2.12 (-8.08%)
Closing price 03:59 PM Eastern
Extended Trading
$23.88 -0.19 (-0.77%)
As of 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Ono Pharmaceutical stock logo

Ono Pharmaceutical OTCMKTS:OPHLF

$14.55 0.00 (0.00%)
As of 05/1/2026

Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia. The company also provides Glactiv tablets for type 2 diabetes; Forxiga tablets for diabetes; Onoact Intravenous Infusion for tachyarrhythmia; Opalmon tablets to treat peripheral circulatory disorder; Coralan for chronic heart failure; Orencia injections for rheumatoid arthritis; Rivastach patches for Alzheimer's disease; Ongentys tablets for Parkinson's disease; Parsabiv, an intravenous infusion for dialysis patients; Staybla tablets for overactive bladder; Onon capsules and Dry Syrups for bronchial asthma and allergic rhinitis; and JOYCLU intra-articular injection for the improvement of joint function, as well as Recalbon tablets for osteoporosis. In addition, it develops products for hepatocellular and urothelial carcinoma; ovarian, bladder, prostate, pancreatic, gastric, esophageal, colorectal, thyroid, cell lung, and breast cancer; acute myeloid leukemia; solid tumors; myelodysplastic syndrome; melanoma; T-cell lymphoma; tachyarrhythmia; pemphigus; scleroderma; seizures; diabetic polyneuropathy; neurodegenerative diseases; autoimmune diseases; narcolepsy; and thrombosis. The company has a collaboration with Adimab, LLC to discover novel antibody drugs; a research collaboration with Turbine Ltd. to identify and validate novel oncology targets; Harvard University for validating novel therapeutic targets; and a strategic drug discovery collaboration with Sibylla Biotech in central nervous system disorders. The company was founded in 1717 and is headquartered in Osaka, Japan.